Anja H. Loos
Merck (Germany)(DE)
Publications by Year
Research Areas
Statistical Methods in Clinical Trials, Lung Cancer Treatments and Mutations, Health Systems, Economic Evaluations, Quality of Life, Colorectal Cancer Treatments and Studies, Endometrial and Cervical Cancer Treatments
Most-Cited Works
- → Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer(2008)1,636 cited
- → Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening(2005)375 cited
- → Cancer consequences of the Chernobyl accident: 20 years on(2006)239 cited
- → Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000(2004)158 cited
- → Cetuximab Plus Irinotecan in Heavily Pretreated Metastatic Colorectal Cancer Progressing on Irinotecan: MABEL Study(2008)103 cited
- → Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials(2018)94 cited
- → Geographic and temporal variations in cancer of the corpus uteri: Incidence and mortality in pre- and postmenopausal women in Europe(2005)86 cited
- → Reduced incidence of infusion‐related reactions in metastatic colorectal cancer during treatment with cetuximab plus irinotecan with combined corticosteroid and antihistamine premedication(2010)49 cited
- → Comparison of Cardiac Troponin I versus T and Creatine Kinase MB after Coronary Artery Bypass Grafting in Patients with and without Perioperative Myocardial Infarction(2004)46 cited
- → Model-informed approach for risk management of bleeding toxicities for bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1(2022)30 cited